98%
921
2 minutes
20
The exhaled breath represents an ideal matrix for noninvasive biomarker discovery, and exhaled metabolomics have the potential to be clinically useful in the era of precision medicine. In this concise translational review, we specifically address volatile organic compounds in the breath, with a view toward fulfilling the promise of these as actionable biomarkers, in particular, for lung diseases. We review the literature paying attention to seminal work linked to key milestones in breath research; discuss potential applications for breath biomarkers across disease areas and healthcare systems, including the perspectives of industry; and outline critical aspects of study design that will need to be considered for any pivotal research going forward if breath analysis is to provide robust validated biomarkers that meet the requirements for future clinical implementation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544359 | PMC |
http://dx.doi.org/10.1164/rccm.202305-0868TR | DOI Listing |
J Med Educ Curric Dev
September 2025
Department of General Pediatrics, Pediatric Cardiology and Neonatology, Medical Faculty, University Children's Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.
Background: Medical education has been experiencing a transition from time- to competency-based. Since their introduction by Olle ten Cate in 2005, entrustable professional activities are a part of this process. We implemented a set of EPAs for the first 3 years of training at our hospital, encompassed by informational materials for trainees and supervisors.
View Article and Find Full Text PDFExplor Res Clin Soc Pharm
December 2025
Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW, Australia.
Introduction: Pharmacists are essential to healthcare delivery in Australia, making effective workforce planning critical to ensure equitable health outcomes. This study explores factors influencing the career decisions of Australian pharmacists from diverse demographic and geographical backgrounds with implications for recruitment, retention and policy strategies to address workforce shortages.
Method: We conducted semi-structured interviews between November 2022-February 2024.
J Educ Health Promot
July 2025
Medical Imaging Sciences Department, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates.
Background: Despite significant advancements in healthcare in the United Arab Emirates (UAE), limited research has explored the motivational factors influencing UAE radiography students' choice of this field.
Materials And Methods: Institutional using a cross-sectional survey, to explore motivational factors influencing career decisions among UAE radiography students. It was conducted in 2023 and involved 100 students from four universities across the UAE.
Appl Psychol Health Well Being
October 2025
School of Health Sciences, 11 Airlie Place, University of Dundee, Dundee, Scotland, UK.
Virtual Reality nature (VRn) may deliver mental health and wellbeing without being outside in real nature. The main objective of this systematic review and meta-analysis was to report effects of VRn on mental health and wellbeing of students in higher education. To be eligible, participants were higher education students, the intervention was VRn, the outcome variable was a mental health parameter, and the study design was experimental.
View Article and Find Full Text PDFPLOS Glob Public Health
September 2025
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Youth living with perinatally acquired HIV (APHIV) in India face layered challenges; peer-led differentiated care models show promise but remain underexplored. We examined multi-stakeholder perceptions within the I'mPossible Fellowship, a peer-support DSD intervention addressing APHIV health, education, and livelihoods From May-December 2023, we enrolled three stakeholder groups: (1) intervention deliverers (APHIV "fellows" 18-27 yrs), (2) facilitators ("supervisors" of APHIV), and (3) recipients(APHIV "peers" in care, 8-26 yrs). We conducted interviews with 8 fellows (75% female, mean age 22.
View Article and Find Full Text PDF